+ Watch TEVA
on My Watchlist
A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories.
Nice yield. Excellent long-term cash flow growth. Low risk. Reasonably good financial strength. Low debt. Low forward P/E. Good ratios of EV/EBITDA and gross income to total assets. Major holdings by value mutual funds.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions